Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
27.02 USD | +2.89% | -2.74% | -11.38% |
Mar. 25 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
Mar. 22 | Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.38% | 2.6B | |
+9.16% | 45.97B | |
+51.37% | 43.93B | |
+11.20% | 42.34B | |
-8.59% | 28.27B | |
+16.40% | 27.18B | |
-19.34% | 19.44B | |
+13.95% | 13.83B | |
+31.56% | 12.4B | |
+10.63% | 11.45B |
- Stock
- Equities
- Stock Intellia Therapeutics, Inc. - Nasdaq
- News Intellia Therapeutics, Inc.
- Intellia Therapeutics Reports Wider Q2 Net Loss; Shares Slip